Tat-Beclin 1 D11 Autophagy Inducing Peptide - Retroinverso form Summary
Tat-D11 [NBP2-49888]: peptides comprising 11 amino acids derived from Beclin 1 linked to the HIV Tat protein with a diglycine linker. These peptides are in the retero-inverso D-configuration. The amino acid sequence of Tat-Beclin 1 D11 is RRRQRRKKRGYGGDHWIHFTANWV (Bio-Techne's exclusive patent license: US Patent 8,802,633).
Cell-penetrating autophagy inducing peptides engineered in 2013 were demonstrated to induce autophagy through interaction with the autophagy suppressor GAPR-1/GLIPR2 (Nature, 2013; PMID 23364696). These Tat-Beclin 1 peptides were comprised of AA 267-284 of the autophagy inducer Beclin 1 (18 amino acids), a diglycine linker, and 11 amino acids of the HIV Tat protein transduction domain. Tat-B...eclin 1 peptides were re-engineered to remove 7 AA from the beclin 1 domain. These shorter peptides, Tat-D11 [NBP2-49888] and Tat-L11 [NBP2-49886], demonstrate enhanced autophagy inducing function over the original Tat-Beclin 1 peptides and the scrambled control peptide Tat-L11S [NBP2-49887]. Tat-D11 and Tat-L11 are potent autophagy inducers which function both in vitro and in vivo to specifically induce autophagy. Tat-D11 and Tat-L11 peptides are comprised of 11 amino acids of the autophagy-inducing region of beclin 1 fused to the HIV Tat protein. Both Tat-D11 and Tat-L11 peptides function by binding the negative regulator of autophagy GAPR-1/GLIPR2. Upon peptide binding, beclin 1 bound to GARP-1 is released, resulting in beclin 1 mediated autophagosome formation and autophagy induction. Data indicate Tat-D11 is more potent than both Tat-L11 and Tat-Beclin 1 in vivo. In addition, initial data derived from HeLa cells also suggests Tat-D11 is more potent than Tat-L11 in vitro. However, ongoing experiments indicate Tat-L11 may be more potent than Tat-D11 in select cell lines.
| Protein/Peptide Type
Autophagy Inducing Peptide
Packaging, Storage & Formulations
Store at -20C in powder form. Store at -80C once reconstituted.
This product is supplied lyophilized. Purity is >= to 97% (HPLC)
Reconstitute with DMSO or water to desired concetration. Note:- D11 should NOT be reconstituted at a concentration greater than 5 mM.
Note: Tat-L11 and Tat-D11, are exclusively available from Novus Biologicals (Bio-Techne's exclusive patent license: US Patent 8,802,633).
Alternate Names for Tat-Beclin 1 D11 Autophagy Inducing Peptide - Retroinverso form
- Autophagy Inducing peptide
- Tat-Beclin 1 peptide
- Tat-Beclin 1
- Tat-Beclin peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed
for 1 year from date of receipt.
Publications for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888) (0)
There are no publications for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888) (0)
There are no reviews for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888).
By submitting a review earn points towards our Rewards Program.
- 250 points for product review
- 500 additional points for an image with your product review
- Double points (500) if you are the first to review this product
- Double points (1000) if you are the first to review this product with an image
Product General Protocols
View specific protocols for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888):
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
FAQs for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888) (0)
Additional Tat-Beclin 1 Products
Research Areas for Tat-Beclin 1 Autophagy Inducing Peptide (NBP2-49888)
Find related products by research area.
Blogs on Tat-Beclin 1